Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous bone marrow-derived stem cells + mesenchymal stem cells
- Development stage
- Phase 2
- Lead developer
- Stem Cells Arabia
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intrathecal
01
Overview
This combination cell therapy involves the transplantation of purified autologous bone marrow-derived stem cells and mesenchymal stem cells (MSCs) for the treatment of cerebral palsy. Developed by Stem Cells Arabia, the treatment utilizes the patient's own cells, which are harvested from the bone marrow, purified, and then re-administered via intravenous and intrathecal routes. The therapeutic rationale is based on the ability of these stem cell populations to migrate to sites of brain injury, where they may exert neuroprotective effects, stimulate endogenous repair mechanisms through paracrine signaling, and modulate inflammatory processes to improve functional outcomes in pediatric patients.
- Other names
- purified autologous bone marrow-derived stem cells and mesenchymal stem cellsStem Cell Therapy for Cerebral Palsy
Beyond the preview
Go deeper on autologous bone marrow-derived stem cells + mesenchymal stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous bone marrow-derived stem cells + mesenchymal stem cells.